Comac Medical is excited to announce our participation in the inaugural Outsourcing in Clinical Trials China 2025, taking place on September 3–4 2025, in Suzhou. This event marks a significant step in our expansion into the Asia-Pacific region, reflecting our commitment to global collaboration in clinical research.

Attending on behalf of Comac Medical is Chief Commercial Officer, Christian Bulhmann and Business Development Director, Thomas Dent, who is eager to engage with industry leaders and explore opportunities for partnership within China’s dynamic clinical trial landscape.​

The conference agenda is rich with insights into China’s evolving clinical research environment, featuring sessions on:

🔹Regulatory Developments: Navigating the latest changes in China’s healthcare regulations.

🔹Strategic Collaborations: Building effective partnerships with local CROs and biopharmaceutical companies.

🔹Emerging Technologies: Exploring digital tools and innovative methodologies shaping the future of clinical trials in China.​

With over 250 attendees expected, including a significant proportion of C-suite executives, the event offers a prime opportunity for networking and knowledge exchange.​

Visit us at our Booth #9 to learn more about how Comac Medical can support your clinical trial needs in the Asia-Pacific region. We look forward to connecting with you in Suzhou in September!